Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Xiaoling Zhong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Electroacupuncture ameliorates cognitive impairment and white matter injury in vascular dementia rats via activating HIF-1α/VEGF/VEGFR2 pathway
Yang, Y., Rao, T., Jiang, Y., Zhan, Y., Cheng, J., Yin, Z., Ma, K., Zhong, X., Guo, X. & Yang, S., 7 May 2025, In: Neuroscience. 573, p. 364-380 17 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Limited efficacy of adjunctive therapy in a case of severe herpes simplex virus encephalitis: A case report and literature review
Zhong, X. L., Yang, C. L., Yu, X. L. & Wang, L., Jan 2025, In: IDCases. 41, e02307.Research output: Contribution to journal › Article › peer-review
Open Access -
Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
Zhong, X., Yang, Y., Wei, S. & Liu, Y., Mar 2025, In: PLoS ONE. 20, 3 March, e0309849.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson’s Disease
Yu, X., Zhu, K., Wang, T., Li, H. Y., Zhang, X., Zhong, X. & Wang, L., 2025, In: Neuropsychiatric Disease and Treatment. 21, p. 511-524 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
Yang, Y., Wei, S., Tian, H., Cheng, J., Zhong, Y., Zhong, X., Huang, D., Jiang, C. & Ke, X., 2024, In: Frontiers in Pharmacology. 15, 1439115.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations